Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), Key Incident Monitoring and Management System program (KIMMS), Sydney, Australia.
Biochem Med (Zagreb). 2020 Jun 15;30(2):020704. doi: 10.11613/BM.2020.020704. Epub 2020 Apr 15.
The Key incident monitoring and management system program (KIMMS) program collects data for 19 quality indicators (QIs) from Australian medical laboratories. This paper aims to review the data submitted to see whether the number of errors with a higher risk priority number (RPN) have been reduced in preference to those with a lower RPN, and to calculate the cost of these errors.
Data for QIs from 60 laboratories collected through the KIMMS program from 2015 until 2018 were retrospectively reviewed. The results for each QI were averaged for the four-year average and coefficient of variation. To review the changes in QI frequency, the yearly averages for 2015 and 2018 were compared. By dividing the total RPN by 4 and multiplying that number by the cost of recollection of 30 AUD, it was possible to assign the risk cost of these errors.
The analysis showed a drop in the overall frequency of incidents (6.5%), but a larger drop in risk (9.4%) over the period investigated. Recollections year in Australia cost the healthcare industry 27 million AUD. If the RPN data is used, this cost increases to 66 million AUD year.
Errors with a higher RPN have fallen more than those with lower RPN. The data shows that the errors associated with phlebotomy are the ones that have most improved. Further improvements require a better understanding of the root cause of the errors and to achieve this, work is required in the collection of the data to establish best-practice guidelines.
关键事件监测和管理系统项目(KIMMS)程序从澳大利亚医学实验室收集 19 个质量指标(QIs)的数据。本文旨在回顾提交的数据,以了解具有较高风险优先数(RPN)的错误数量是否已减少,而不是那些具有较低 RPN 的错误数量,并计算这些错误的成本。
回顾了 KIMMS 计划从 2015 年到 2018 年收集的来自 60 个实验室的 QIs 数据。四年平均和变异系数的每个 QI 的结果进行平均。为了审查 QI 频率的变化,比较了 2015 年和 2018 年的年平均值。通过将总 RPN 除以 4 并将该数字乘以 30 澳元的回忆成本,可以分配这些错误的风险成本。
分析显示,在所调查的期间内,事件的总体频率(6.5%)有所下降,但风险下降更大(9.4%)。澳大利亚每年的回忆成本为医疗保健行业带来 2700 万澳元的损失。如果使用 RPN 数据,这一成本将增加到每年 6600 万澳元。
具有较高 RPN 的错误比具有较低 RPN 的错误下降更多。数据显示,与采血相关的错误得到了最大程度的改善。进一步的改进需要更好地了解错误的根本原因,为此,需要在数据收集方面开展工作,以制定最佳实践指南。